1. Home
  2. BGLC vs BDRX Comparison

BGLC vs BDRX Comparison

Compare BGLC & BDRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BGLC
  • BDRX
  • Stock Information
  • Founded
  • BGLC N/A
  • BDRX 2000
  • Country
  • BGLC Malaysia
  • BDRX United Kingdom
  • Employees
  • BGLC 30
  • BDRX N/A
  • Industry
  • BGLC Medical Specialities
  • BDRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • BGLC Health Care
  • BDRX Health Care
  • Exchange
  • BGLC Nasdaq
  • BDRX Nasdaq
  • Market Cap
  • BGLC 9.1M
  • BDRX 9.6M
  • IPO Year
  • BGLC N/A
  • BDRX N/A
  • Fundamental
  • Price
  • BGLC $0.50
  • BDRX $0.79
  • Analyst Decision
  • BGLC
  • BDRX Strong Buy
  • Analyst Count
  • BGLC 0
  • BDRX 1
  • Target Price
  • BGLC N/A
  • BDRX $8.00
  • AVG Volume (30 Days)
  • BGLC N/A
  • BDRX 4.2M
  • Earning Date
  • BGLC N/A
  • BDRX 04-19-2024
  • Dividend Yield
  • BGLC N/A
  • BDRX N/A
  • EPS Growth
  • BGLC N/A
  • BDRX N/A
  • EPS
  • BGLC N/A
  • BDRX N/A
  • Revenue
  • BGLC N/A
  • BDRX $482,278.00
  • Revenue This Year
  • BGLC N/A
  • BDRX N/A
  • Revenue Next Year
  • BGLC N/A
  • BDRX N/A
  • P/E Ratio
  • BGLC N/A
  • BDRX N/A
  • Revenue Growth
  • BGLC N/A
  • BDRX N/A
  • 52 Week Low
  • BGLC N/A
  • BDRX $0.67
  • 52 Week High
  • BGLC N/A
  • BDRX $9.64
  • Technical
  • Relative Strength Index (RSI)
  • BGLC 49.09
  • BDRX 41.69
  • Support Level
  • BGLC $0.46
  • BDRX $0.91
  • Resistance Level
  • BGLC $0.59
  • BDRX $1.20
  • Average True Range (ATR)
  • BGLC 0.04
  • BDRX 0.14
  • MACD
  • BGLC 0.01
  • BDRX -0.00
  • Stochastic Oscillator
  • BGLC 29.93
  • BDRX 8.39

About BGLC BioNexus Gene Lab Corp Common stock

BioNexus Gene Lab Corp through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of 11 different diseases.

About BDRX Biodexa Pharmaceuticals plc American Depositary Shs

Biodexa Pharmaceuticals Plc is a drug delivery technology company focused on improving the bio-delivery and bio-distribution of medicines. The company combines approved and developed medications with its proprietary and innovative drug delivery technologies to provide compelling products that have the potential to powerfully impact the lives of patients.

Share on Social Networks: